Evaluation of the Medicines Transparency Alliance Phase 1, 2008-2010

The Medicines Transparency Alliance (MeTA) was created in recognition of the key importance of access to medicines. These documents report on: Establishing a framework for MeTA in pilot countries; gaining government commitment and establishing sectoral and national committees. Delivering against the MeTA objectives in countries; progress towards data identification, disclosure, changes in practice and logframe… Read more




css.php